Zymeworks Inc.
ZYMENASDAQHealthcare● Active
$23.98
$-0.06(-0.26%)
Market Cap$1.8B
P/E Ratio—
52W High$29.75
52W Low$11.51
Zymeworks Inc. (ZYME) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ZYME · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.11B | $0.08B | $0.08B | $0.41B | $0.03B |
| Cost of Revenue | $0.00B | $0.00B | $0.14B | $0.00B | $0.00B |
| Gross Profit | $0.11B | $0.08B | ($0.07B) | $0.41B | $0.03B |
| Gross Margin %(computed) | 100.00% | 100.00% | -88.11% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.14B | $0.13B | $0.14B | $0.21B | $0.20B |
| G&A Expenses | $0.06B | $0.06B | $0.07B | $0.07B | $0.04B |
| Total Operating Expenses | $0.20B | $0.21B | $0.07B | $0.28B | $0.24B |
| Operating Income | ($0.09B) | ($0.14B) | ($0.14B) | $0.13B | ($0.22B) |
| Operating Margin %(computed) | -87.33% | -179.69% | -181.62% | 31.64% | -808.22% |
| Interest Income | $0.01B | $0.02B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.08B) | ($0.12B) | ($0.12B) | $0.14B | ($0.21B) |
| Income Tax Expense | $0.00B | $0.01B | ($0.00B) | $0.01B | ($0.00B) |
| Net Income | ($0.08B) | ($0.12B) | ($0.12B) | $0.12B | ($0.21B) |
| Net Margin %(computed) | -76.56% | -160.80% | -156.13% | 30.14% | -794.01% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.06 |
| Wtd Avg Shares | 0.08B | 0.08B | 0.07B | 0.07B | 0.05B |
| EBITDA | ($0.08B) | ($0.11B) | ($0.12B) | $0.14B | ($0.21B) |
| EBITDA Margin %(computed) | -76.84% | -142.36% | -158.79% | 34.54% | -772.45% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Zymeworks Inc. data
About Zymeworks Inc. (ZYME) Income Statement
Zymeworks Inc. (ZYME) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ZYME reported revenue of $0.11B, gross profit of $0.11B (gross margin 100.00%), and net income of ($0.08B) — a net profit margin of -76.56%.
Frequently asked questions
ZYME · 4 questionsZymeworks Inc. (ZYME) reported revenue of $0.11B for 2025, up 38.9% year-over-year.
ZYME revenueZYME salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08